Lowell, MA · Founded 2015 · Privately Held (backing)
Developer of a wearable blood pressure monitoring device designed to accurately and continuously measure blood pressure. Dynocardia is based in Lowell, MA and was founded in 2015. Its last reported valuation was $12.5 million in Jan 2021. It has raised $8.3 million across 4 recorded rounds; the latest was a $1.2 million seed round in Mar 2025.
Last reported valuation
$12.5M
Oct 2026
Priced at
—
Total raised
$8.3M
Last round
Seed Round
Mar 2025
Cap table — not yet on record
Dynocardia's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Dynocardia with a free account
·The complete investor list: 11 names
·Watch Dynocardia: the Monday email on marks, rounds and moves